CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDED AND RESTATED DISTRIBUTION AND...Distribution and License Agreement • November 4th, 2009 • Xenoport Inc • Pharmaceutical preparations • New York
This Amended and Restated Distribution and License Agreement (hereinafter, the “Restated License Agreement”), which amends and restates the Distribution and License Agreement, dated as of the 1st day of December, 2005 (hereinafter, as amended to date pursuant to that certain First Amendment, dated as of the 15 th day of May, 2009, the “Original Agreement”), between XenoPort, Inc., a Delaware corporation having a place of business at 3410 Central Expressway, Santa Clara, CA 95051, United States of America (“XenoPort”), and Astellas Pharma Inc., a Japanese corporation having a place of business at 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo, 103-8411, Japan (“Astellas”), is entered into and made effective as of the 31st day of October, 2009 (the “Restatement Effective Date”). Each of XenoPort and Astellas shall be a “Party” and, together, the “Parties.”
